Abbott India Q1 net up 71% to Rs 51 cr

Tags: Companies
Drug firm Abbott India today posted 71.42 per cent rise in its net profit to Rs 50.93 crore for the first quarter ended June 30.

The company had posted a net profit of Rs 29.71 crore for the same period of previous fiscal.

Net sales of the company rose to Rs 516.91 crore for the first quarter, as compared to Rs 429.68 crore during the same period of previous fiscal, Abbott India Ltd said in a filing to the BSE.

In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.

These transactions made it one of the largest health care companies in the country. It now employs about 14,000 people in India, making it the firm's largest employee base outside the US.

Shares of Abbott India were trading at Rs 2,330 apiece on the BSE, up 7.08 per cent from its previous close.


  • The govt needs to change its mindset and strategies on divestment

    Divestment of public sector units (PSUs) through offer for sale route is one area where the performance of all governments, irrespective of party, had


Stay informed on our latest news!


Sandeep Bamzai

First among equals, always

Might is right is an adage as old as the ...

Zehra Naqvi

When differences fracture the cause

It is precisely the minor differences in people who are ...

Shona Adhikari

Owais Husain searches for a lost homeland

The seventh edition of the Mumbai Public Art Festival (PAF) ...